Skip to main content
. 2021 Jan 15;7(2):e654. doi: 10.1097/TXD.0000000000001106

Table 3.

Patients undergoing primary LTx with chemotherapy

Author, y Primary LTx Age (mo) Pre-LTx chemo Pre-LTx chemo cycles Post-LTx chemo cycles Post-LTx chemo
Schluckebier D, 2016 1 120 Ifosfamide, vincristine, dactinomycin 4 9 Ifosfamide, vincristine, dactinomycin
Shi Y, 2017 10 108 NA NA NA NA
Techavichit P, 2016 1 264 Ifosfamide doxorubicin 5 None None
Walther, 2014 1 156 Ifosfamide doxorubicin 6 4 Vincristine, actinomycin D, cyclophosphamide
Walther, 2014 1 132 Ifosfamide doxorubicin. 5 1 Ifosfamide
Ismail, 2013 1 4 Cislplatin doxorubicin 2 NA Cyclophosphamide, doxorubicin vincristine
Rohan V, 2014 2 32 NA NA NA NA
Chen LE, 2006 1 73 Cisplatin, adriamycin, vincristine, Ifosfamide 4 None None
Chen LE, 2006 1 60 Cisplatin, adriamycin, vincristine 1 None None
Okajima H, 2009 1 180 Vincristine, actinomycin cyclophosphamide Stopped early: side effects NA Vincristine, actinomycin, cyclophosphamide
Dower NA, 2000 1 72 Ifosfamide, carboplatin, etopiside 2 None None
Khan Z, 2017 1 252 Ifosfamide doxorubicin 5 None None
Dhanasekaran R, 2012 1 648 Adriamycin ifosfamide dacarbacine 10 mo None None

LTx, liver transplant; NA, data not available; none, did not have chemotherapy.